LuxCath is the leader in using fluorescence and optics to directly view lesions during cardiac ablation procedures. The company’s breakthrough technology offers the potential for dramatic evolution in the way ablation procedures are performed by assessing tissue contact and enabling direct lesion progression monitoring. LuxCath’s patented solution aims to ensure the quality of catheter lesions at the moment they are made. LuxCath enables constant optical tissue contact assessment and provides valuable lesion formation and progression information during each ablation.
| Website | http://www.luxcath.com |
| Revenue | $5 million |
| Employees | 3 (0 on RocketReach) |
| Founded | 2012 |
| Address | 100 High St Fl 28, Boston, Massachusetts 02110, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+11 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Manufacturing General, Monitoring Equipment, Manufacturing, Other Healthcare Technology Systems |
| Keywords | Cardiac Ablation, Fluorescence Imaging, Optical Imaging, Electrophysiology, Catheter Ablation, Heart Ablation, Diagnostic Imaging, Fluoroscopy, Arrhythmia Treatment, Ep Lab, Interventional Cardiology, Medical Devices, Minimally Invasive, Surgical Technology, Cardiology, Medical Technology, Healthcare Technology |
| Competitors | Medtronic, Abbott, Stryker, BD, Cardinal Health, Boston Scientific, CONMED Corporation, Terumo, Smiths Medical, Halyard Health +41 more (view full list) |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 334 Companies, NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular LuxCath, LLC employee's phone or email?
LuxCath, LLC Questions
The LuxCath, LLC annual revenue was $5 million in 2026.
LuxCath, LLC is based in Boston, Massachusetts.
The NAICS codes for LuxCath, LLC are [334, 33, 339].
The SIC codes for LuxCath, LLC are [38, 384].
Related Companies
